Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rovelli

Showing results (71-80 of 179) with videos related to

Pageof 18
Sort By:
The International Journal of Biological Markers|July 5, 2003
Changes in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancerP Lissoni, F Rovelli, F Malugani, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1995
Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancerP Lissoni, S Pittalis, F Rovelli, et al.
Journal of the American College of Cardiology|November 1, 1987
GISSI trial: early results and late follow-up. Gruppo Italiano per la Sperimentazione della Streptochinasi nell'Infarto MiocardicoF Rovelli, C De Vita, G A Feruglio, et al.
Postgraduate Medical Journal|January 1, 1986
Haemodynamic, radionuclide ventriculography and ergometric evaluation of captopril treatment in congestive heart failureE Gronda, B Brusoni, M Mangiavacchi, et al.
Tumori|February 28, 1990
Correlation of serum interleukin-2 levels, soluble interleukin-2 receptors and T lymphocyte subsets in cancer patientsP Lissoni, S Barni, F Rovelli, et al.
The International Journal of Biological Markers|October 1, 1992
Effect of interferon-alpha on soluble interleukin-2 receptor and tumor necrosis factor increase during immunotherapy with interleukin-2P Lissoni, A Ardizzoia, F Rovelli, et al.
Oncology|July 1, 1994
Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 aloneP Lissoni, S Barni, M Cazzaniga, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1996
Immunomodulatory properties of a pineal indole hormone other than melatonin, the 5-methoxytryptopholP Lissoni, S Pittalis, F Rovelli, et al.
European Urology|April 15, 2000
Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemiaP Lissoni, M Mandalà, F Rovelli, et al.
Cardiology|May 1, 1996
Predictive value of sequential testing in screening for silent myocardial ischemia in asymptomatic middle-aged men (the ECCIS Project)D Antoniucci, F Seccareccia, A Menotti, et al.
Pageof 18

Showing results (71-80 of 179) with videos related to

Sort By:
Pageof 18
The International Journal of Biological Markers|July 5, 2003
Changes in circulating VEGF levels in relation to clinical response during chemotherapy for metastatic cancerP Lissoni, F Rovelli, F Malugani, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1995
Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancerP Lissoni, S Pittalis, F Rovelli, et al.
Journal of the American College of Cardiology|November 1, 1987
GISSI trial: early results and late follow-up. Gruppo Italiano per la Sperimentazione della Streptochinasi nell'Infarto MiocardicoF Rovelli, C De Vita, G A Feruglio, et al.
Postgraduate Medical Journal|January 1, 1986
Haemodynamic, radionuclide ventriculography and ergometric evaluation of captopril treatment in congestive heart failureE Gronda, B Brusoni, M Mangiavacchi, et al.
Tumori|February 28, 1990
Correlation of serum interleukin-2 levels, soluble interleukin-2 receptors and T lymphocyte subsets in cancer patientsP Lissoni, S Barni, F Rovelli, et al.
The International Journal of Biological Markers|October 1, 1992
Effect of interferon-alpha on soluble interleukin-2 receptor and tumor necrosis factor increase during immunotherapy with interleukin-2P Lissoni, A Ardizzoia, F Rovelli, et al.
Oncology|July 1, 1994
Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 aloneP Lissoni, S Barni, M Cazzaniga, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1996
Immunomodulatory properties of a pineal indole hormone other than melatonin, the 5-methoxytryptopholP Lissoni, S Pittalis, F Rovelli, et al.
European Urology|April 15, 2000
Paradoxical stimulation of prolactin secretion by L-dopa in metastatic prostate cancer and its possible role in prostate-cancer-related hyperprolactinemiaP Lissoni, M Mandalà, F Rovelli, et al.
Cardiology|May 1, 1996
Predictive value of sequential testing in screening for silent myocardial ischemia in asymptomatic middle-aged men (the ECCIS Project)D Antoniucci, F Seccareccia, A Menotti, et al.
Pageof 18